Persephone

Persephone is pioneering the use of synthetic biology for the development of microbial products that impact patient and infant health. Persephone is building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems. The company was founded in the summer of 2017 by synthetic and metabolic engineering pioneers Stephanie Culler, PhD, and Steve Van Dien, PhD.

Financing Round: Seed

Location: San Diego, CA

Vertical(s): Health, Bio Tech

Founder(s): Stephanie Culler, PhD; Steve Van Dien, PhD

Oct 19, 2023
Persephone Biosciences Announces New Collaboration With Kroger Health to Launch AMBROSIA Food as Medicine Study
BioSpace

Oct 17, 2023
Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit
Cision

July 27, 2023
Building a Better Microbiome
proto.life

April 27, 2023
“Cancer & the Gut Biome” with Stephanie Culler, Ph.D.
Angel Invest Boston

Jan 24, 2023
Kroger Health Establishes Clinical Trial Site Network to Increase Reach and Access to Research Studies
Cision

Sept 20, 2022
Persephone Biosciences Announces First Participant Enrolled in the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response
GlobeNewswire

July 19, 2022
Persephone Biosciences, Pioneers In Synthetic Biology, Lands $15M In Seed Funding
Grit Daily

July 19, 2022
Can bacteria in your gut boost cancer therapies? A San Diego startup thinks so
The San Diego-Union Tribune

July 19, 2002
Persephone puts poop to work to explore and heal your gut microbiome
TechCrunch